Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Thyroid Nodule 1Thyroid Neoplasms 1Sarcoma, Synovial 1Sarcoma 1Neurofibrosarcoma 1Malignant mesenchymal tumor 1Liposarcoma 1Leiomyosarcoma 1Histiocytoma, Malignant Fibrous 1Hemangiosarcoma 1Hemangiopericytoma, Malignant 1Fibrosarcoma 1Chondrosarcoma, Extraskeletal Myxoid 1Carcinoma, Lobular 1COVID-19 1Breast Neoplasms 1Breast Carcinoma In Situ 1

Interventions

Amplified Fragment Length Polymorphism Analysis 2entrectinib 1Vinorelbine 1Trastuzumab 1Radiomics 1Pharmacogenomic Testing 1Neoadjuvant Therapy 1Molecular Diagnostic Techniques 1Letrozole 1Goserelin 1Gene Expression Profiling 1Epirubicin 1Docetaxel 1Cyclophosphamide 1Capecitabine 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Carcinoma, Lobular × Molecular Diagnostic Techniques × Clear all
NCT00536718 2013-08-12

Genetics of Women With Lobular Carcinoma in Situ of the Breast

National Cancer Institute (NCI)

Unknown
3,000 enrolled
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Lobular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡